Mark Goldston
Analyst · Canaccord Genuity
Thanks very much, Bruce, and good afternoon, everyone. Welcome to the Body Q1 2026 Earnings Call. Last quarter, we reported our Q4 and full year '25 results, a transformational year where we achieved positive operating income and adjusted net income for the first time since going public. Today, I'm pleased to report the momentum continued in Q1 of 2026. Let me start with the numbers and the Q1 '26 financial highlights. Total revenue for Q1 was $54.3 million, which came in above the high end of our guidance. As a reminder, and as we've consistently noted, Q3 2026 will mark the first quarter where we can make direct year-over-year comparisons that fully reflect our new business model as the legacy MLM business will have completely cycled out of both periods. More importantly, we delivered our third consecutive quarter of net income at $2.3 million compared to a net loss of $5.7 million in Q1 of 2025. Operating income was $3.1 million, marking our third consecutive quarter of profitability on this metric. We posted our 10th consecutive quarter of positive adjusted EBITDA at $8 million, up from $3.7 million in the prior year, and gross margin remained strong at 71.8% and within our guidance. As of March 31, our cash balance was $36.6 million against outstanding debt principal of approximately $25 million, providing financial flexibility to execute our growth strategy. The operational discipline that we've built in over the past 2-plus years is now embedded in how we run the business. We've lowered our EBITDA breakeven from over $900 million in 2022 to approximately $180 million currently, giving us tremendous operating leverage and the ability to invest strategically in growth initiatives without sacrificing profitability. As we discussed in March, 2026 is the year we're unleashing our innovation pipeline. With our strong balance sheet and substantially improved financial position, we've got the flexibility to fund our retail expansion and the innovation pipeline without compromising the financial discipline that delivered this turnaround. The cornerstone of our growth strategy is a pivot towards a heavier emphasis on nutrition, and that will be executed through an omnichannel strategy spanning direct-to-consumer to retail distribution. This represents entry into a nutrition products category with a market opportunity that is more than 12x the size of the digital fitness category. We're bringing iconic brand names like P90X and Insanity and Shakeology to retail with very high aided brand awareness. Now we're freed from the MLM commission constraints, and we can price our new nutritional products at dramatically lower price points than we have done in the past. And in the case of Shakeology, we can utilize a much smaller form factor, the 7 serving size, which will give us a $34.95 retail price point versus our previous price point, which was $129 for a 30-serve pack. This represents a significant opportunity for us. As many of you may know, in my career, I've got a long history in the consumer products or CPG industry from my days at Johnson & Johnson and Bristol-Myers, Clarel, Cheesebrough Ponds, Revlon and as President of Fabberget, which became Fabberget Elizabeth Arden. And I got background at Reebok, L.A. Gear and the huge flower company, FTD. I've been responsible for the creation and/or marketing of billions of dollars worth of some of the most successful consumer products of all time sold through retail distribution. And that's one of our major areas of expansion that I brought to body. The process of submitting samples through our broker sales organization, Advantage Solutions, securing buyer commitments and then waiting for the retailer shelf set planogram to be updated is about a 6- to 12-month process with inflexible adherence dates. We're right now in the midst of that process. And over the next 60 to 90 days, we expect to see which retailers will be adding Shakeology and the P90x line of nutritional supplements. Look, I'm sure you've seen the recent state of acquisitions in the CPG industry, whether it be Fuel, Grooms, Bloom, Alani, Poppy and a host of other companies that have sold for between $1 billion to $2 billion in the past year with brand names that while we have great respect for, are not nearly as well known as the P90X and even Shakeology brand names. So the potential for creating massive brand equity value for shareholders of body within the nutritional supplement and energy drink industry for body is potentially the single largest mid- to long-term opportunity that we've got at the company. Speaking of securing retail distribution, last week, we announced that Shakeology will be carried in more than 80 Sprouts Farmers Market stores around the country, starting in late May, early June. And we just secured a partnership with Kahi Distributors, which is one of the 2 largest distributors of natural organic and fresh products to the grocery industry. And this will give us the opportunity to reach the 30,000 grocery, supermarket and online channels that are covered by the KiHi distribution network. And in late-breaking news, we just announced in a press release yesterday that Shakeology will now be carried by Vitamin Shoppe across its more than 640 stores all over the U.S.A. later this year, with Vitamin Shop taking all 5 of the Shakeology flavor variants in our new 7-serve $34.99 retail price packaging. This exciting news, along with the Sprouts Farmers market news and the Kihi distribution deal will mark the first time that Shakeology, which is a $4 billion cumulative sales brand with more than 1 billion cumulative servings, the first time it will be available in retail stores across the U.S.A. On the next quarterly earnings call, we hope to have an update on more exciting retail partners for the Shakeology brand and new retailers signed up to carry the P90x line of supplements and the retail stores who will be carrying the Insanity and P90x energy drinks in the Southern California test market will be running later this summer. One of the truly unique and compelling aspects of the new body retail distribution initiative as a consumer product company is that we fundamentally created a virtual consumer products company. So what do I mean by that? Well, we've outsourced virtually every aspect of our supply chain and distribution infrastructure. Manufacturing is outsourced to best-in-class contract manufacturers. Sales and retail distribution are managed through our outside partner, Advantage Solutions. Fulfillment and logistics of all of the retail orders are handled by a third-party logistics provider or a 3PL, and we're evaluating the use of purchase order financing and accounts receivable factoring to optimize our working capital as it relates to the retail project. What we keep in-house are the core competencies that drive our competitive advantage. Those are marketing, brand management, product innovation and R&D. So this asset-light model gives us exceptional financial flexibility, minimal capital requirements and importantly, the ability to scale rapidly without proportional increases in fixed costs since this structure moves the majority of those costs to a variable base cost based on usage and demand. So in conclusion, our financial turnaround has created massive operating leverage, giving us the ability to invest strategically in high-return initiatives while maintaining profitability. We're excited about the opportunities ahead, particularly as we move into the second half of 2026 and then beyond. This year marks the opening of our nutritional innovation pipeline. We are actively in the process of developing new products, securing retail placement and building market acceptance. While we expect to see initial traction in the second half of 2026, the substantial yield from these initiatives will materialize in 2027 and beyond as our retail presence expands and our multichannel strategy fully takes hold. We've built a resilient financial foundation that positions us to capitalize on significant growth opportunities in both nutrition and digital fitness, and we're taking a disciplined, methodical approach to ensure we execute this transition successfully. I'll now turn it over to Carl to discuss our operational progress and product innovation strategy. Carl?